Clinical trial
Validation of the Prostate Cancer Assay - Beta+Pivotal
NCT02742259
Study timeline
Study start (estimated)2016-05-01Date precision: month
Registry last updated2019-03-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Prostate Cancer, CTCunresolved
Interventions
Blood DrawDEVICE
Sponsors & collaborators
Celsee Diagnosticslead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02742259 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.